Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10532022
Whole stablized olive mill process water, production thereof and uses thereof
granted -
US 10519222
Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region
granted -
US 10517890
Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles
granted -
US 10513521
Compositions and methods for inhibiting BMP
granted -
US 10512671
IL-24 to treat inflammatory diseases
granted -
US 10513533
Tunicamycin related compounds with anti-bacterial activity
granted -
US 10512673
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
granted -
US 10513542
Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof
granted -
US 10507187
Regenerative tissue grafts and methods of making same
granted -
US 10508106
Bicyclic BET bromodomain inhibitors and uses thereof
granted -
US 10500238
Use of gram negative species to treat atopic dermatitis
granted -
US 10500269
Human rotavirus vaccine strains and diagnostics
granted -
US 10500264
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted -
US 10501507
Griffithsin mutants
granted -
US 10501528
Immunoglobulin single variable domain antibody against RSV prefusion F protein
granted -
US 10494683
Nitrate- and nitrite-reducing probiotic feed additive
granted -
US 10493087
Sialylation-increasing therapies for diseases associated with oxidative stress
granted -
US 10494435
Human monoclonal antibodies specific for CD22
granted -
US 10485771
Methods of regulating cannabinoid receptor activity-related disorders and diseases
granted -
US 10485879
Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues
granted -
US 10485792
Sustained release delivery systems for the prevention and treatment of head and neck cancers
granted -
US 10480031
Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)
granted -
US 10478415
Ketone bodies to protect tissues from damage by ionizing radiation
granted -
US 10472412
Bispecific multivalent fusion proteins
granted